Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Scientific Reports (4)
Leukemia (3)
Nature Communications (3)
Nature Cancer (2)
Signal Transduction and Targeted Therapy (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (14)
Amendments and Corrections (1)
Correspondence (1)

Subject Check one or more subjects to show results from those subjects only.

Biophysics
Biotechnology
Cancer
Cardiology
Cell biology
Chemistry
Computational biology and bioinformatics
Diseases
Drug discovery
Endocrinology
Environmental social sciences
Genetics
Health care
Mathematics and computing
Medical research
Pathogenesis
Risk factors
Stem cells
Structural biology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–16 of 16 results

Advanced filters: Author: Shuhua Zou Clear advanced filters

A glucose kinase-independent HK2 activity prevents TNF-induced cell death by phosphorylating RIPK1

TNF-induced RIPK1-mediated cell death is implicated in various human diseases. Here Zou et al. demonstrate that HK2 acts as a protein kinase to inhibit RIPK1 activity and suppress cell death by constitutive phosphorylation of RIPK1 at serine 32.

Tianhao Zou
Ran Liu
Jinyang Gu
ResearchOpen Access13 Nov 2025
Nature Communications

Volume: 16, P: 1-21
Impact of rare non-coding variants on human diseases through alternative polyadenylation outliers

Rare variants (RVs) significantly impact human diseases. Here, the authors conducted a comprehensive cross-tissue analysis of alternative polyadenylation outliers (aOutliers) and discovered a unique class of aOutliers-associated RVs with a large effect on disease.

Xudong Zou
Zhaozhao Zhao
Lei Li
ResearchOpen Access16 Jan 2025
Nature Communications

Volume: 16, P: 1-17
Origin of the multi-phasic quenching dynamics in the BLUF domains across the species

Here the authors combine 19 F NMR and femtosecond transient absorption to characterise the structural origin of the multiphasic quenching dynamics in various species of BLUF domains, highlighting the importance of the heterogeneous active-site H-bond network.

Yalin Zhou
Siwei Tang
Dongping Zhong
ResearchOpen Access20 Jan 2024
Nature Communications

Volume: 15, P: 1-11
Hierarchical sparse Bayesian learning with adaptive Laplacian prior for single image super-resolution

Mingming Qi
Yue Zhou
Shuhua Xu
ResearchOpen Access17 Oct 2025
Scientific Reports

Volume: 15, P: 1-17
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial

Kim and colleagues perform a phase 2 clinical trial (ELM-2) of odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma and report on the primary analyses of the efficacy and safety profile.

Won Seog Kim
Tae Min Kim
Umar Farooq
ResearchOpen Access17 Mar 2025
Nature Cancer

Volume: 6, P: 528-539
High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia

Shuhua Yi
Yuting Yan
Lugui Qiu
Research22 Jan 2021
Leukemia

Volume: 35, P: 2412-2415
PTNS: patent citation trajectory prediction based on temporal network snapshots

Mingli Ding
Wangke Yu
Shuhua Wang
ResearchOpen Access14 Oct 2024
Scientific Reports

Volume: 14, P: 1-15
Author Correction: Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial

Won Seog Kim
Tae Min Kim
Umar Farooq
Amendments and CorrectionsOpen Access16 Apr 2025
Nature Cancer

Volume: 6, P: 907
Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome

Zi-Jiang Chen and colleagues report a genome-wide association analysis for polycystic ovary syndrome (PCOS) in Han Chinese. They identify eight new susceptibility loci for PCOS in this population.

Yongyong Shi
Han Zhao
Zi-Jiang Chen
Research12 Aug 2012
Nature Genetics

Volume: 44, P: 1020-1025
Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study

Ying Yu
Yuxi Li
Shuhua Yi
ResearchOpen Access12 Mar 2025
Signal Transduction and Targeted Therapy

Volume: 10, P: 1-8
Intratumoral genetic heterogeneity and number of cytogenetic aberrations provide additional prognostic significance in chronic lymphocytic leukemia

Shuhua Yi
Zengjun Li
Lugui Qiu
Research28 Jul 2016
Genetics in Medicine

Volume: 19, P: 182-191
Real-time predictive model of extrauterine growth retardation in preterm infants with gestational age less than 32 weeks

Liang Gao
Wei Shen
Xiaohong Liu
ResearchOpen Access05 Jun 2024
Scientific Reports

Volume: 14, P: 1-13
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma

Jian Cui
Yuntong Liu
Gang An
ResearchOpen Access12 Apr 2024
Leukemia

Volume: 38, P: 1299-1306
Identifying myoglobin as a mediator of diabetic kidney disease: a machine learning-based cross-sectional study

Ruoru Wu
Zhihao Shu
Hongwei Lu
ResearchOpen Access10 Dec 2022
Scientific Reports

Volume: 12, P: 1-14
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma

Gang An
Yuting Yan
Lugui Qiu
Research07 Oct 2019
Leukemia

Volume: 34, P: 578-588
A gemcitabine-based regimen followed by autologous stem cell transplantation show high efficacy and well tolerance in malignant lymphoma

Huimin Liu
Wei Liu
Dehui Zou
Correspondence07 Apr 2022
Bone Marrow Transplantation

Volume: 57, P: 1017-1020